|
Note from
Selective Mutism Foundation, Inc.
Free treatment for Selective Mutism is included as an anxiety disorder.
|
STUDY:
Fluoxetine
Treatment of Anxiety and Depression and Associated Brain Changes in
Children and Adolescents
Summary:
This study will
determine if fluoxetine (Prozac®) is effective for treating
anxiety or depression in children and adolescents.
The study will also use functional magnetic resonance
imaging (fMRI) to learn more about how the brain functions in
children/adolescents taking this medication for anxiety or
depression.
Boys and girls ages 8 to 17
with anxiety and/or depression may be eligible for this outpatient
treatment study. Participants
will first meet with a psychiatrist or psychologist for 2 weekly
sessions of talk therapy. Those
who remain anxious or depressed after these 2 weeks will have the
option of receiving treatment with fluoxetine daily for 8 weeks,
or cognitive-behavioral therapy once a week for 8 weeks.
Parents also have the option of choosing a placebo for the
8 weeks. They will be seen by a doctor approximately weekly for 8
weeks to talk and complete verbal and written exercises.
Participants will be interviewed both individually and
together with a parent to assess general mood, degree of
nervousness, and behavior.
Those who have not improved by the end of the study will be
offered other treatment for 1 to 3 months, and NIMH clinicians
will help with finding subsequent aftercare.
Those who improve with treatment will continue therapy at
NIMH until an outside physician is able to assume responsibility
for monitoring the medication.
All procedures and medications associated with the research are
provided at no cost to participants, and transportation expenses
are reimbursed by NIMH.
Principal Investigator:
Daniel Pine, M.D.
For eligibility
criteria and detailed information about this study: http://www.clinicaltrials.gov/ct/gui/show/
NCT00018057
To
refer a patient, call NIMH:
301-496-5645
|
